ACP
MLTX icon

Acuta Capital Partners’s MoonLake Immunotherapeutics MLTX Stock Holding History

Acuta Capital Partners’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-93,500
Closed -$982K – 37
2022
Q4 		$982K Buy
+93,500
New +$982K 0.6% 27